Elizabeth Pan

Germline alterations among Hispanic men with prostate cancer.

R. Nussbaum, S. Nielsen, J. Parsons, 2022, Prostate cancer and prostatic diseases.

Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials

I. Derweesh, James D. Murphy, C. Kane, 2021, Cancer.

Germline alterations among Hispanic men with prostate cancer

R. Nussbaum, James D. Murphy, J. Parsons, 2021, Prostate Cancer and Prostatic Diseases.

Real-world Practice Patterns and Safety of Concurrent Radiotherapy and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.

T. Choueiri, B. Beuselinck, S. Pal, 2022, European urology oncology.

Adjuvant Therapy in Renal Cell Carcinoma: Are we ready for prime time?

I. Derweesh, R. McKay, Elizabeth Pan, 2022, Kidney Cancer.

Managing First-Line Metastatic Renal Cell Carcinoma: Favorable-Risk Disease.

R. McKay, Elizabeth Pan, C. Malvar, 2023, Hematology/oncology clinics of North America.

Analysis of CDK12 alterations in a pan‐cancer database

P. Tamayo, A. Shabaik, R. Kurzrock, 2021, Cancer medicine.

A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE).

E. V. Van Allen, C. Kyriakopoulos, G. Shapiro, 2023, Molecular cancer therapeutics.